Current management of patients with severe von Willebrand disease type 3: a 2012 update.
about
Human plasma-derived FVIII/VWD concentrate (Biostate): a review of experimental and clinical pharmacokinetic, efficacy and safety dataG protein-dependent basal and evoked endothelial cell vWF secretion.Congenital Type III von Willebrand's disease unmasked by hypothyroidism in a Shetland sheepdog.Pharmacokinetics, efficacy, and safety of a plasma-derived VWF/FVIII concentrate (VONCENTO) for on-demand and prophylactic treatment in patients with von Willebrand disease (SWIFT-VWD study).
P2860
Current management of patients with severe von Willebrand disease type 3: a 2012 update.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Current management of patients with severe von Willebrand disease type 3: a 2012 update.
@en
type
label
Current management of patients with severe von Willebrand disease type 3: a 2012 update.
@en
prefLabel
Current management of patients with severe von Willebrand disease type 3: a 2012 update.
@en
P2860
P356
P1433
P1476
Current management of patients with severe von Willebrand disease type 3: a 2012 update.
@en
P2093
Augusto B Federici
Paula James
P2860
P356
10.1159/000338208
P577
2012-06-19T00:00:00Z